1. Home
  2. CBSH vs MIRM Comparison

CBSH vs MIRM Comparison

Compare CBSH & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commerce Bancshares Inc.

CBSH

Commerce Bancshares Inc.

HOLD

Current Price

$58.37

Market Cap

8.4B

Sector

Finance

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$100.90

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBSH
MIRM
Founded
1865
2018
Country
United States
United States
Employees
4976
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
7.2B
IPO Year
2008
2019

Fundamental Metrics

Financial Performance
Metric
CBSH
MIRM
Price
$58.37
$100.90
Analyst Decision
Hold
Strong Buy
Analyst Count
8
13
Target Price
$58.28
$119.85
AVG Volume (30 Days)
773.4K
598.0K
Earning Date
04-21-2026
05-06-2026
Dividend Yield
2.15%
N/A
EPS Growth
4.39
74.59
EPS
2.06
N/A
Revenue
N/A
$19,138,000.00
Revenue This Year
$17.43
$26.22
Revenue Next Year
$3.43
$22.04
P/E Ratio
$28.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$46.99
$63.23
52 Week High
$61.09
$130.00

Technical Indicators

Market Signals
Indicator
CBSH
MIRM
Relative Strength Index (RSI) 49.33 47.86
Support Level $57.73 $88.08
Resistance Level $60.72 $105.20
Average True Range (ATR) 0.91 3.23
MACD -0.16 0.71
Stochastic Oscillator 39.57 58.39

Price Performance

Historical Comparison
CBSH
MIRM

About CBSH Commerce Bancshares Inc.

Commerce Bancshares Inc operates as the bank holding company for Commerce Bank. The bank is engaged in the general banking business, providing a broad range of retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals, businesses, and municipalities. The company has three reportable segments. The Commercial segment provides lending, leasing, deposit, payment, and cash management services to business and government customers. The Retail Banking segment offers consumer deposits, consumer lending, mortgage banking, and debit and credit card services through its branch network. The Wealth segment provides trust, estate planning, brokerage, and investment management services to individual and institutional clients.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.

Share on Social Networks: